Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05875987 · ClinicalTrials.gov registry record
Evaluation of the Quantra QStat System in Obstetric Patients
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 50
- Enrollment target
NCT05875987: Completed study, sponsored by HemoSonics.
NCT05875987 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05875987 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
Primary Outcome
Coagulation function assessed by Quantra Clot Time (CT, sec) and activated partial thromboplastin (aPTT, sec) test
Interventions
- DEVICE Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2024-05-10 |
What the finished NCT05875987 record still lists
NCT05875987 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT05875987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05875987 about?
NCT05875987 is a clinical study titled "Evaluation of the Quantra QStat System in Obstetric Patients". This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
What is the current status of trial NCT05875987?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2023-06-01. Estimated completion is 2024-05-10.
What interventions are being tested in trial NCT05875987?
The interventions under investigation include: Quantra System (DEVICE).
Who is sponsoring clinical trial NCT05875987?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI